Clinical Epidemiology and Ageing

Absence of efficacy of everolimus in neurofibromatosis 1-related plexiform neurofibromas: results from a phase IIa trial.

Zehou O, Ferkal S, Brugières P, Barbarot S, Bastuji-Garin S, Combemale P, Valeyrie-Allanore L, Sbidian E, Wolkenstein P J Invest Dermatol. 2018.
DOI: 10.1016/j.jid.2018.09.016

Ajouter un commentaire

3 + 0 =